N-acetylation has been described as a detoxification reaction for aromatic amines; however, there is only limited data available showing that this metabolic conversion step changes their genotoxicity potential. To extend this database, three aromatic amines, all widely used as precursors in oxidative hair dye formulations, were chosen for this study: p-phenylenediamine (PPD), 2,5-diaminotoluene (DAT) and 4-amino-2-hydroxytoluene (AHT). Aiming at a deeper mechanistic understanding of the interplay between activation and detoxification for this chemical class, we compared the genotoxicity profiles of the parent compounds with those of their N-acetylated metabolites. While PPD, DAT and AHT all show genotoxic potential in vitro, their N-acetylated metabolites completely lack genotoxic potential as shown in the Salmonella typhimurium reversion assay, micronucleus test with cultured human lymphocytes (AHT), chromosome aberration assay with V79 cells (DAT) and Comet assay performed with V79 cells. For the bifunctional aromatic amines studied (PPD and DAT), monoacetylation was sufficient to completely abolish their genotoxic potential. Detoxification through N-acetylation was further confirmed by comparing PPD, DAT and AHT in the Comet assay using standard V79 cells (N-acetyltransferase (NAT) deficient) and two NAT-proficient cell lines,V79NAT1*4 and HaCaT (human keratinocytes). Here we observed a clear shift of dose-response curves towards decreased genotoxicity of the parent aromatic amines in the NAT-proficient cells. These findings suggest that genotoxic effects will only be found at concentrations where the N-acetylation (detoxifying) capacity of the cells is overwhelmed, indicating that a 'first-pass' effect in skin could be taken into account for risk assessment of these topically applied aromatic amines. The findings also indicate that the use of liver S-9 preparations, which generally underestimate Phase II reactions, contributes to the generation of irrelevant positive results in standard genotoxicity tests for this chemical class.
Introduction
About 60% of women and 5-10% of men in Western countries are using hair dyes. Oxidative hair dyes, which are the most widely used, work as a bicomponent system: primary intermediates, usually monocyclic p-phenylenediamines (PPD), are mixed with couplers, usually meta-substituted aminophenols, and hydrogen peroxide in an alkaline cream formulation. While the starting materials easily diffuse into the hair, the large coloured hair dye molecules formed by the polymerisation of primary intermediates and couplers are trapped in the hair matrix, thereby creating a permanent colour. The primary intermediates and couplers are also known as hair dye precursors.
While for most in vivo toxicology studies performed with aromatic amines, the chosen route of exposure was oral via feed or gavage, the exposure relevant for hair dyes is through the dermal route. Considerations relevant for a comparison between the oral and dermal route of exposure are the low systemic availability of dermally applied aromatic amines from hair dye formulations (1) (2) (3) , as well as the specific metabolic competence of human skin to detoxify these compounds as highlighted below.
In vitro genotoxicity testing currently relies on addition of exogenous metabolic activation systems usually prepared from induced rat liver (S-9) to simulate in vivo metabolism. This approach does not reflect a realistic exposure scenario for hair dyes since the metabolic profile generated in human skin is fundamentally different from that generated in rat liver. Together with some other well-discussed factors such as the lack of normal cell cycle control and repair (4) , the abundance of activating enzymes and lack of Phase II enzymes in S-9 can lead to a high percentage of misleading positive test results in standard in vitro genotoxicity assays. In general, positive in vitro results can be clarified with subsequent animal experiments. However, the seventh amendment to the EU Cosmetics Directive, which came into effect in March 2009, banned animal testing for the endpoint of genotoxicity for cosmetic ingredients marketed in the EU. In a situation when no in vivo follow-up tools can be applied, the investigation of the impact of the route of exposure on the metabolic and genotoxic profile is a way forward to address positive in vitro genotoxicity assay results, among other available options such as the use of micronucleus and comet assays in three-dimensional reconstituted human skin models (5) .
While the standard textbook knowledge about aromatic amine metabolism tends to generalise and sometimes includes heterocyclic, polycyclic and biphenyl-like aromatic amines into one single category, we will concentrate on monocyclic mono-and bifunctional aromatic amines that are generally recognised as being less carcinogenic (6) . One of the key steps in activating aromatic amines is CyP450 oxidation. This reaction will generally convert aromatic amines to N-hydroxylamines, which subsequently can be O-acetylated or sulfated, leading finally to reactive nitrenium ions, which can generate DNA damage and trigger a carcinogenic effect in the bladder (7) . While the activation reaction will compete in an in vivo situation with detoxifications such as N-acetylation, the formation of the oxidised N-hydroxylamine precursor molecule is fueled by the use of S-9 in in vitro genotoxicity assays.
Apart from its low relevance for dermal exposure, the use of S-9 also has several other disadvantages: (i) Prolonged exposure is not possible due to cytotoxicity of S-9 mix, (ii) reactive metabolites are formed in the extracellular space and need to diffuse into the cells to react with DNA, (iii) conjugation ('Phase II') reactions are underrepresented, and (iv) several CyP450 isoforms are not induced or even inhibited by the chemicals used to generate enriched S-9 (Aroclor, phenobarbital/naphthoflavone) (3) .
Another important metabolic pathway for aromatic amines is N-acetylation, which is catalysed by N-acetyltransferases (NAT). Several studies in cells, tissue models, animals and humans have demonstrated that N-acetylation is the predominant initial metabolic reaction for monocyclic aromatic amines. The resulting N-acetylated species are mostly excreted unchanged via the urine (1, 2, 8, 9) .
Moreover, several investigators (8, 10, 11) have found no evidence of CyP450-mediated N-hydroxylation in human hepatocytes and reconstructed human skin models with PPD, p-aminophenol and several other hair dye precursors. N-acetylation and O-sulfation were the predominant metabolic pathways, followed by O-glucuronidation. Kato et al. (12) investigated the effect of N-acetylation on genotoxicity of heterocyclic arylamines, which caused a substantial reduction in the mutagenic potential compared with the parent compounds. Gupta et al. (13) also observed a lack of mutagenicity when comparing o-toluidine with its N-acetylated metabolites. This theory was confirmed by Garrigue et al. (14) in 2006, who demonstrated the absence of a genotoxic potential in monoand diacetylated PPD compared with PPD in the Ames, micronucleus and HPRT (hypoxanthineguanine phosphoribosyl transferase) tests. A simplified overview on major metabolic pathways of aromatic amines is shown in Figure 1 .
To overcome the restrictions of S-9-simulated metabolism, several groups have created transformed cell lines expressing one or more enzymes involved in xenobiotic metabolism (16) (17) (18) (19) (20) . This approach enables the investigation of a specific metabolic pathway without interference from competing reactions, and the direct comparison of two cell lines differing only in the expression of a single enzyme. Such cell lines expressing human enzymes including V79NAT1*4 cells that contain the NAT 1 enzyme were derived from Chinese hamster V79 lung cells, which are well established in genotoxicity testing. The wild-type cells possess a stable karyotype and do not have noteworthy metabolic capacity under standard culture conditions except for some prostaglandin-H-synthase, glutathion transferase and DT diaphorase activities (21) (22) (23) .
V79NAT1*4 cells may be less relevant than HaCaT (=spon-taneously immortalised adult skin cells) for human risk assessment for hair dyes since they are deficient in p53 and do not originate from the site of first contact organ with regard to hair dye use. However, they are a good choice for mechanistic investigations since they are expected to be identical to their NAT1-deficient progenitors with regard to DNA repair capacity, susceptibility to direct-acting genotoxins and glutathione content/activity.
This study expands the evaluation of hair dyes beyond PPD and its N-acetylated metabolites (14) to include the two widely used hair dye precursors, 2,5-diaminotoluene (DAT) and 4-amino-2-hydroxytoluene (AHT), and their respective N-acetyl derivatives. Furthermore, the above-described V79/ V79NAT1*4 cell line pair was used to compare the genotoxicity response to the above-mentioned aromatic amines, an approach that, to our knowledge, has not been taken previously for this chemical class. By comparing the genotoxicity profiles of the parent compounds with their N-acetylated metabolites, as well as the dose-response curves from the cells featuring different capacities for N-acetylation, we were aiming at a deeper mechanistic understanding of the interplay between genotoxicity and detoxification for this chemical class.
Materials and methods

Test substances
Chemical structures of DAT, PPD and AHT and their acetylated derivatives are shown in Figures 2-4 , respectively.
Chemicals supplied/distributed by
Acros Organics, Geel, Belgium: PPD. Obtained through our in-house synthesis department: Di-Ac-PPD, 2-mono-Ac-DAT, 5-mono-Ac-DAT, Di-Ac-DAT, Ac-AHT. Sigma-Aldrich, Buchs, Switzerland: mono-Ac-PPD. Wella Production, Hünfeld, Germany: DAT, AHT. All test compounds had a purity of at least 99.5% as determined via high-performance liquid chromatography with UV detection.
Metabolic activation system
Rat liver S-9 mix was supplied by either MolTox, Boone, NC, USA (Aroclor 1254 induced) or Harlan Laboratories, Rossdorf, Germany (β-naphthoflavone/ phenobarbital induced).
Cells/bacteria
Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 were originally obtained from Prof. B.N. Ames, Berkeley, CA, USA, and were regularly checked for correct genotype.
For the Comet assay, Chinese hamster V79 cells were obtained from Dr. S. Brendler-Schwaab, Bayer AG, Wuppertal, Germany. Prof. H.-R. Glatt, DifE, Potsdam-Rehbrücke, Germany provided the V79NAT1*4 cells, which were stably transfected to express the human NAT1*4 gene (24) . The HaCaT cell line was obtained from Prof. N. Fusenig, University of Heidelberg, Germany (25) . All cells were kept under the culture conditions recommended by their providers/vendors to enable comparisons with other laboratories.
For the in vitro micronucleus test, lymphocytes from healthy, non-smoking male and female volunteers were used. Comet assay: All agarose solutions were prepared with Ca/Mg-free phosphate buffered saline (PBS). The basal agarose layer on the slides was prepared from a 1% solution of normal melting agarose (Sigma-Aldrich), which was air-dried before use. Cell suspensions were mixed with 0.7% low-melting agarose (Cambrex Seaplaque). Trypsin (0.25%), PBS, culture media and fetal calf serum (FCS) were purchased from PAA (Pasching, Austria). SYBR Gold was obtained from Molecular Probes and diluted 1:10000 in Tris-HCl, pH 7.2. Lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, pH 10, 10% dimethylsulphoxide (DMSO), 1% Triton X-100, 1% N-lauryl-sarcosinate) was prepared freshly prior to each experiment. Unwinding-/elektrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH 13.2) and neutralisation buffer (0.4 M Tris pH 7.5) were prepared in large batches to ensure optimal inter-experimental comparability.
Additional materials
Solvents and positive control substances DMSO was used as vehicle control. The following substances were used as positive controls: Salmonella reversion (Ames) assay: 2-aminoanthracene, mitomycin C, methylmethanesulfonate (MMS), sodium azide, 4-nitro-o-phenylene-diamine, 2-nitrofluorene, 9-aminoacridine, 2-aminofluorene. Comet assay: MMS. Micronucleus assay: 4-nitroquinoline-1-oxide, cyclophosphamide and vinblastine
Dosing solutions
Stock solutions of all test substances were freshly prepared in DMSO and diluted to appropriate concentrations using DMSO. The maximum solvent concentration for final treatment was 1% v/v in medium.
Test protocols
Salmonella reversion assay. The Ames test is the most widely used assay for detection of mutagenicity. The tests were conducted according to OECD 471 (for details, refer to) (26) . Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 were grown in nutrient broth the night before the experiment and mixed with the test substance, agar and S-9 mix or buffer before pouring onto minimal agar plates. Induced S-9 rat liver homogenate was used at a total protein concentration of 1-1.9 µg per plate. For each concentration, triplicates were analysed. In all, 100 µl of bacterial suspension, 100 µl of solvent or test substance and 500 µl of S-9 mix or buffer was added to 2 ml molten soft agar, vortexed and poured onto the surface of 25 ml bottom agar. After solidification, plates were inverted and incubated at 37°C for at least 48 hours. Colonies were counted using a Perceptive Instruments Sorcerer Colony Counter. In case of a negative result, the experiment was repeated independently.
Comet assay. The Single Cell Gel Electrophoresis Assay, also known as 'Comet assay', is a proven and sensitive method to detect primary DNA damage in almost any cell type (27, 28) . In the pH 13.2 version, it detects DNA strand breaks, which may be caused by direct-acting clastogens or through alkali-labile sites. The alkaline Comet assay is suited for the sensitive detection of agents causing DNA strand breaks and covalently bound adducts (29, 30) . The latter are converted to single-strand breaks by alkali treatment or through the action of cellular DNA repair enzymes (31) . The Comet assay measures primary DNA damage and, unlike the in vitro micronucleus assay, does not require cell proliferation.
Comet culture conditions. Cells were grown in standard 75-cm 2 plastic flasks and subcultivated twice per week. Cell culture recommendations given by the original authors were employed for each cell line in order to retain comparability with other laboratories performing similar studies. All experiments have been performed with low passage cultures, prior to the 20th subcultivation of the respective cells. Culture medium contained 5 and 10% serum for V79NAT1*4 and V79/HaCaT cells, respectively. All cell lines were regularly checked for mycoplasm contamination.
Comet treatment. Cells were seeded into six-well plates, and treatment was performed for 3 hours in medium with reduced serum (2%) during the logarithmic growth phase, with the exception of 48-hour experiments where the cell layer was confluent for the final hours except at cytostatic/ cytotoxic concentrations of the test substance. Experiments with 48-hour treatment time were conducted with culture medium instead of treatment medium. Single cultures were used in the individual experiments and repeated independently.
Comet cell harvest. At the end of treatment, cell monolayers were washed with PBS and trypsinised. The enzyme was stopped by addition of culture medium. An aliquot of the cell suspension was used for cytotoxicity/ viability assessment while the other was diluted 10-fold with 0.7% lowmelting agarose at 37°C. After layering on precoated slides, coverslips were applied and the agarose was gelled at 4°C followed by careful removal of the coverslip. The slides were lysed for at least 1 hour (at 4°C), DNA was unwound for 20 minutes in electrophoresis buffer and electrophoresis was performed in fresh electrophoresis buffer at ~1 V/cm for 30 minutes, followed by neutralisation and a final dehydration/fixation step in ethanol. From each culture, triplicate slides were prepared and further processed in at least two different electrophoresis runs. Slides were placed at random to minimise possible border effects in the tank. A professional grade level was used to ensure that the electrophoresis tank was placed horizontally. All steps following lysis were conducted in a cold room at ~4°C, and all work was done under dim light.
Cytotoxicity assessment. An aliquot of the trypsinised cells was analysed with a Neubauer haematocytometer using the trypan blue dye exclusion (TBDE) test to distinguish viable from dead cells. Viability is calculated as the ratio between the numbers of viable and total cells.
Evaluation. Dried Comet slides were stained in Coplin jars with SYBR Gold (1:10 000 in 0.05 M Tris-HCl pH 7.2) prior to evaluation with a ×20 objective and a CCD camera (AVT, Germany) using the software 'Comet Assay IV' (CA4) from Perceptive Instruments, UK. Coding of slides was done by a third person using random numbers and opaque tape. The slides were scanned in a meandering way to ensure that no cell was scored twice (32) . The microscope stage was moved an arbitrary distance, and all cells in the field of view were to be measured with the exception of overlapping and necrotic cells ('hedgehogs'). Fifty cells per slide (150 per dose group) were evaluated, and all parameters given by CA4 were recorded, but only tail intensity (TI%) and Olive tail moment (OTM) were chosen as parameters for evaluation.
Data handling. The arithmetic mean of the TI% and OTM data from 50 cells per slide was calculated and used as statistical/experimental unit. Mean and SD values from the three slides were given for each concentration level investigated.
Statistics. There is no generally accepted statistical method for the evaluation of in vitro Comet data available (33, 34) . In this study, the following statistical approach was taken. The arithmetic mean values (each representing 50 cells per slide) of one culture were subjected to a Komolgorov-Smirnov test for normality followed by a one-way analysis of variance procedure using Dunnett's test to compare multiple data sets against a common negative control, in this case the three slides from the DMSO-treated cultures. A P-value of ≤0.05 was considered significant. The criteria to decide if a test substance is deemed to possess a genotoxic potential were primarily based on biological relevance of the effects that includes a comparison of the effect with historical control data (see Supplemental information, supplementary Tables SI1 and  SI2 , available at Mutagenesis Online). The results of the statistical assessment were mainly used to define the lowest effective concentration (LOEC).
Graphics. To facilitate the comparison between different cell lines, TI% data were normalised to represent fold increase over concurrent controls and were plotted together with the respective cytotoxicity data. Standard deviations were calculated from the normalised slide mean data. Data are shown for one representative experiment, but independent repeat experiments have been performed in all cases. The positive control (30 µg/ml MMS) induced at least a 3-fold increase in TI% compared with concurrent controls in all experiments (data not shown). OTM data are not displayed graphically but can be found in their respective tables in the Supplemental information, available at Mutagenesis Online .
In vitro micronucleus assay with human lymphocytes. The detection of micronuclei in human lymphocytes is well suited for the detection of both clastogenic and aneugenic potential of a test compound. Following incubation with cytochalasin B (Cyto B), cells are unable to divide, but karyokinesis is still possible. Hence, evaluation of binucleated cells analyses only the fraction of cells after first mitosis (35, 36) .
In vitro micronucleus culture conditions. Whole-blood cultures were established by placing 0.4 ml of the pooled heparinised blood into medium containing 20% (v/v) FCS and 50 µg/ml gentamycin, so that the final volume following addition of S-9 mix/KCl and the test substance was 10 ml. Phytohaemagglutinin (PHA) was included in the culture medium (~2%) to stimulate division of the lymphocytes. Blood cultures were incubated at 37°C ± 1°C and rocked continuously.
In vitro micronucleus treatment. In the initial experiments, the test chemicals were added 24 hours following culture initiation. Cells were exposed for 20 hours in the absence of S-9 followed by a 28-hour recovery period and for 3 hours in the presence of S-9 followed by a 45-hour recovery period. Cells were harvested at 72 hours.
In the confirmatory experiments, cells were treated at48 hours following culture initiation and harvested at 96 hours. Again, treatment in the absence of S-9 was for 20 + 28 hours and for 3 + 45 hours in the presence of S-9. Cytochalasin B (6 µg/ml) was present during the final ~28 hours of incubation in both cases. DMSO was used as negative control. Rat liver S-9 mix (Aroclor 1254 induced) was used at a final concentration of 2%.
At the defined sampling time, cultures were centrifuged (300 × g for 10 minutes), resuspended in 0.075 M KCl at 37°C for 5 minutes and fixed by dropping the KCl suspension into fresh, cold methanol/glacial acetic acid (3:1, v/v, 'Carnoy's reagent'). Lymphocytes were kept at 4°C in fixative for at least one day, gently dropped and spread onto multiple clean, dry microscope slides. After the slides had dried, the cells were stained with filtered 4% (v/v) Giemsa in Gurr's buffer, pH 6.8. The slides were rinsed, dried and mounted with coverslips. Slides were scored for proportions of mononucleate, binucleate and multinucleate cells, and the replication index (RI) was calculated based on the analysis of 500 cells per replicate (1000 per dose). The RI was determined using the following formula: The 95% reference range of historical negative controls ranges up to 1.2% and the observed range up to 1.65% following 24-hour PHA stimulation, while after 48-hour PHA stimulation, both values are 1.0%.
Chromosomal aberration assay with V79 cells
According to OECD technical guideline 473, Chinese hamster V79 lung cells were treated with DAT in the presence and in the absence of rat liver S-9 mix for 4 hours each, followed by a recovery period of 14 hours. Two and half hours after addition of Colcemid, cells were swollen in hypotonic KCl and fixed with freshly prepared Carnoy's reagent (MeOH and glacial acetic acid 3:1, v/v). After Giemsa staining, slides were evaluated for visible chromosomal damage. Gaps were recorded but not included in the calculation of aberration rates. Since clastogenicity was detected after 4 hours of treatment, no repeat experiment with an extended treatment period has been performed.
General acceptance and evaluation criteria for the genotoxicity assays used
An assay was considered acceptable if values of the solvent controls were within or close to the 95% reference range of historical solvent controls and the positive control led to a substantial genotoxic effect that fulfills the criteria for a positive response.
Evaluation of results was based on four criteria: 1) Strength of the effect (magnitude and/or statistical significance) 2) Dose-response relationship 3) Reproducibility (inter-/intraexperimental) 4) Relation to the historical range of negative controls A test item was considered positive if all of the criteria were met (clear, statistically significant effect, which is reproducible, dose related and exceeds the historical control range), while it was considered negative if none of the criteria was met. If one or more but not all of the above criteria were met, the results were discussed case by case with regard to their biological relevance. The first concentration that showed a statistically significant difference to solvent controls (P ≤ 0.05) was considered as LOEC (37) .
Results
2,5-Diaminotoluene
Salmonella reversion assay. DAT caused a weak increase in revertant colony counts without metabolic activation (~3-fold) only in TA98 at a concentration of 1000 µg per plate (not shown graphically), but caused a very strong increase in strains TA100, TA1535, TA98 and TA1537 following metabolic activation with S-9. The latter two strains showed revertant colony counts of >50-fold over controls at a concentration of 1000 µg DAT per plate, with higher concentrations leading to a decrease in revertant colony counts and thinning of bacterial background lawn growth due to toxic effects (for TA 98 +S-9 data, see Figure 5 , for data on other strains: see Supplemental information, available at Mutagenesis Online).
In vitro chromosomal aberration assay in V79 cells. DAT induced a significant increase in structural chromosomal aberrations in a study compliant with Good Laboratory Practice (GLP) using V79 cells at concentrations of 10 µg/ml without S-9 and 200 µg/ml with S-9. The clastogenic action was not associated with strong cytotoxicity measured as a decrease in mitotic index or cell number. No indication of an aneugenic potential was observed, as evidenced by lack of endoreduplication or polyploidy. See supplementary Table SI4 , available at Mutagenesis Online, for experimental data.
Comet assay. The lowest concentration of DAT investigated, 20 µg/ml, already elicited a strong DNA damaging effect in standard V79 cells following 3-hour incubation ( Figure 6 , detailed data: supplementary Table SI5 , available at Mutagenesis Online). When NAT-proficient V79NAT1*4 cells were exposed in the same way, there was no increase in DNA damage detectable up to 60 µg/ml. Only at the three highest tested concentrations (≥80 µg/ml), did DAT lead to a statistically significant increase in DNA damage. HaCaT cells were even less susceptible to DAT, and 100 µg/ml was regarded as the LOEC. Viability as detected by the TBDE method showed a relevant (>70%) decrease only after treatment with the highest Fig. 5 . Salmonella typhimurium reversion assay. TA98 bacteria were exposed to DAT and its three N-acetylated metabolites in the presence of metabolic activation. Average revertant colony counts and standard deviations are shown. Note the discontinuous ordinate. 
N-acetylated metabolites of DAT Salmonella reversion assay. None of the three possible N-acetylated metabolites of DAT caused a biologically relevant increase in revertant colony counts in any of the five strains, while some toxic effects were seen at the highest concentrations tested. All experiments were reproduced in independent repeats (data not shown). See Figure 5 
In vitro micronucleus assay. 2-Mono-Ac-DAT and Di-Ac-DAT did not induce a biologically relevant increase of micronuclei in human lymphocytes, neither in the absence nor in the presence of metabolic activation when tested up to 10 mM (1642 and 2062 µg/ml), indicating a lack of clastogenic or aneugenic potential of these metabolites (see supplementary Tables SI9  and SI10 , available at Mutagenesis Online).
5-Mono-Ac-DAT was not tested with the micronucleus in vitro since it is structurally very closely related to 2-monoAc-DAT, which was negative in the in vitro micronucleus (see supplementary Table SI9 , available at Mutagenesis Online). Furthermore, as described previously, 5-mono-Ac-DAT is negative in the Comet assay, and we would expect that a clastogenic potency of this compound would have been picked up by the Comet methodology (38) (39) (40) .
Comet assay. None of the N-acetylated DAT metabolites induced a biologically relevant increase in any of the Comet parameters measured up to a concentration that equals 10 mM or shows substantial precipitation (see supplementary Table SI11 , available at Mutagenesis Online). Weak cytotoxic effects were seen at the highest concentrations tested, accompanied by slight precipitation. These results confirmed the absence of effects as observed in the micronucleus assay.
p-Phenylenediamine Salmonella reversion assay. In the presence of metabolic activation (S-9), PPD increased the revertant colony count in TA98 and TA1537 >10-fold over solvent controls at concentrations of 33 µg/plate and above, while it did not show a mutagenic potential in any of the five strains in the absence of metabolic activation.. At the highest concentrations investigated, PPD was toxic to the bacteria of most strains, which lead to a decrease in revertant colony counts (toxicity data not shown). See Figure 7 for a comparison of PPD with its two N-acetylated metabolites in strain TA98.
In vitro micronucleus assay. Garrigue et al. (14) have shown that PPD induces micronuclei in human lymphocytes in the presence but not in the absence of S-9, when tested following 24-hour PHA stimulation. In their experiments, micronuclei were induced both with and without metabolic activation when tested following 48-hour PHA stimulation. Without S-9, a lower concentration of PPD was sufficient to induce a statistically significant increase in MNBN, but the maximum magnitude of the effect was more pronounced with S-9.
Comet assay. In our experiments, PPD showed a strong genotoxic effect in V79 cells after 3-hour exposure at concentrations of 100 µg/ml and higher (Figure 8 , for detailed data, see supplementary Table SI12 , available at Mutagenesis Online). In V79NAT1*4 cells, the genotoxic effect was negligible up to the highest tested concentration of 1200 µg/ml, with the exception of one intermediate dose level (600 µg/ml) where a single replicate slide led to a statistically significant response. This incidental increase (12.7% TI) remained well within the 95% reference range of historical solvent controls, and since the following concentration levels do not show any similar effects, it was not regarded as biologically meaningful.
In HaCaT cells, a weak increase was detected at 900 and 1200 µg/ml. The TI% and OTM values were not significantly different from controls. However, the OTM at the highest concentration tested was increased more than twice over concurrent controls and exceeded the 95% reference range of historical solvent controls. Taking into consideration the doserelated increase seen at concentrations of 900 and 1200 µg/ml, we consider this effect biologically relevant.
N-acetylated metabolites of PPD Salmonella reversion assay.
Neither mono-Ac-PPD nor Di-Ac-PPD caused a biologically relevant increase in revertant colony counts in any of the five Salmonella tester strains, and no toxic effects were seen except for a weak decrease in revertant colony counts at the highest dose in TA102 (supplementary Table  SI13 , available at Mutagenesis Online). However, there was a weak increase of revertant colonies in strain TA98 plus S-9 after incubation with mono-Ac-PPD at concentrations of 1000 to 5000 µg/plate. The increase was partially reproduced in an independent repeat experiment (1.9-fold increase over concurrent solvent controls in Experiment 1, and 1.6-fold in Experiment 2; see supplementary Table SI14 , available at Mutagenesis Online) but did not show a clear dose-response relationship since the number of colonies remained constant from 3000 to 5000 µg mono-Ac-PPD per plate. Furthermore, the revertant counts of both experiments remained within the historical negative control range of the assay. The marginal increase is likely attributable to PPD, which is a known impurity in the mono-Ac-PPD sample we have used. Due to its high potency in the Ames test, a small amount of PPD would be sufficient to cause such a marginal increase observed in our study. The experiment with Di-Ac-PPD was also independently repeated and confirmed the negative result (see supplementary Table SI15 , available at Mutagenesis Online).
In vitro micronucleus assay. Mono-Ac-PPD and di-Ac-PPD did not show a genotoxic potential in the human lymphocyte micronucleus assay when investigated by Garrigue et al. (14) and were therefore not further analysed in this study.
Comet assay. Both N-acetylated derivatives of PPD tested in the Comet assay (mono-Ac-PPD and di-Ac-PPD) were devoid of any genotoxic potential up to the highest concentration in the Comet assay with V79 cells (for details, see supplementary Table SI16 , available at Mutagenesis Online).
4-Amino-2-hydroxytoluene Salmonella reversion assay.
No mutagenic or toxic effects in any of the five strains were noted after incubation with up to 5000 µg AHT per plate with and without S-9 in two independent experiments (see supplementary Table SI17 , available at Mutagenesis Online).
In vitro micronucleus assay. Due to the lack of published data on clastogenicity of AHT, we performed a micronucleus study with this compound. In our experiments, while the effects after 24-hour stimulation were less pronounced, AHT lead to a clear increase in the proportion of micronucleated human lymphocytes 48 hours following PHA stimulation in a doserelated manner in the absence of S-9. No strictly dose-related increase was seen in the presence of metabolic activation; however, the effects were statistically significantly different from controls, and the historical negative control range was exceeded under both conditions performed 48 hours following PHA stimulation. Concentrations up to 10 mM (1232 µg/ml) were used and increased toxicity to 61 and 52% (without and with S-9, respectively). In summary, AHT demonstrated a clastogenic effect in human lymphocytes both in the absence and presence of metabolic activation. For detailed results, see supplementary Table SI18 , available at Mutagenesis Online.
Comet assay. Treatment of V79 cells with AHT for 3 hours led to inconclusive results; therefore, longer treatment times were investigated (data not shown). Treatment time of 48 hours was chosen to maximise the sensitivity of the test system for this compound since a clear tendency towards increased sensitivity was seen with longer exposure periods. A genotoxic potential of AHT was observed after 48 hours of incubation with V79 cells starting at the lowest concentration tested (10 µg/ml), while DNA damage in both V79NAT1*4 and HaCaT cells started at substantially higher concentrations, 100 and 31,6 µg/ml, respectively ( Figure 9 . For details, see supplementary Table SI19 , available at Mutagenesis Online).
For all 3-hour treatments, medium with reduced serum content was used to minimise protein adsorption interferences, which possibly could decrease effective concentration of a test substance. For the 48-hour experiments with AHT, we used culture medium with normal serum content since the cells are not able to survive for longer periods without serum.
N-acetylated metabolites of AHT Salmonella reversion assay. We did not perform Salmonella reversion experiments with Ac-AHT since its parent compound was not mutagenic to bacteria; hence, there is no scientific rationale in assuming a mutagenic potential of the N-acetylated derivative. In vitro micronucleus assay. In the absence of metabolic activation, one replicate each of the lowest and the highest concentration showed elevated micronucleus count (1.5 and 1.7% MNBN, respectively), which caused a statistically significant increase at the group mean micronucleus counts for these concentrations (Table I) . On the other hand, one replicate of the solvent control showed a high MNBN rate also (1.6%), and a dose-response relationship was not observed and the mean values of all cultures remained within the historical range of negative controls. Therefore, the initial experiment was judged inconclusive, and a confirmatory experiment with lymphocytes stimulated with PHA for 48 hours was performed. In this experiment, at the intermediate of the three concentrations tested, one replicate showed a weak increase in MNBN (1.9%). Since the increase was an isolated finding, the mean value of all cultures remained within the historical range of negative controls, and the highest tested concentrations did not show any increase despite causing a stronger toxic effect, and the relevance of this observation is questionable.
In the presence of metabolic activation, a statistically significant and substantial increase (4.02%) was observed at the intermediate concentration level analysed following 24 hours of mitogen stimulation. Its biological relevance was questionable since the high and low dose did not show any effect. The lack of a biologically relevant effect was then confirmed by the results of a second (48-hour PHA) and a third repeat experiment (24-hour PHA) in which neither assay showed biologically relevant increases in MNBN cell frequency. The maximum Ac-AHT concentration in these experiments was 10 mM (1652 µg/ml) with S-9, and up to 700 µg/ml without S-9 (cytotoxicity precluded testing at higher concentrations).
Comet assay. Ac-AHT was tested in V79 cells using the same 48-hour exposure period as its parent compound. It was devoid of any genotoxic potential up to the highest concentration (1200 µg/ml, see supplementary Table SI20 , available at Mutagenesis Online). Table II shows an overview of the direct comparison of the parent compounds with their acetylated metabolites. An interpretation of these results can be found below.
Discussion
Two of the three tested parent compounds are mutagenic to bacteria
In the presence of rat liver metabolic activation, both DAT and PPD show a clear increase in revertant colony counts at doses starting around 10 µg/plate in strain TA98. The observed very strong increase in revertants in four of the five strains for DAT is likely caused by its bioactivation through CyP 450's fueled by the addition of S-9 mix, which will convert DAT to its oxidised metabolites. In contrast, PPD, in the presences of S-9, only shows Three independent experiments are shown: two experiments with different PHA growth stimulation period and a repeat experiment. Treatment duration and length of recovery period are followed by metabolic activation condition in brackets. Cytotoxicity is given as reduction of replicative index compared with control. MNBN: micronucleated binculeate cell. *P < 0.05, **P < 0.01, ***P < 0.001. Quadruplicate slides have only been evaluated in the controls of Experiment 1.
an increase in the revertant counts in TA98. The main contributor to this effect possibly is 'Bandrowski's base', a PPD trimer (41) . Very low concentrations of Bandrowski's are sufficient to cause a mutagenic effects in TA98 (42), and it has been demonstrated that it is formed under similar in vitro application conditions, which are, however, not relevant to the human consumer application scenario (43) . Without metabolic activation, PPD does not show a mutagenic potential while DAT is weakly active. In summary, both substances are highly mutagenic in the Salmonella reversion assay, while AHT is negative in this assay.
All hair dye precursors tested are clastogenic to cultured mammalian cells
AHT was clearly mutagenic in the micronucleus test performed with human lymphocytes. The same is true for PPD (14) , while DAT was not investigated in this study but caused chromosome aberrations in V79 cells at concentrations of ≥10 µg/ml in the absence and ≥200 µg/ml in the presence of metabolic activation. Since the sensitivity of the chromosomal aberration (CA) and the in vitro micronucleus assay have been demonstrated to be comparable (44, 45) and the effects in the CA were observed at low concentrations, we assume that DAT would lead to a positive result in the in vitro micronucleus assay. The clastogenic effect of PPD and, to a lesser extent, AHT was potentiated by S-9 mix, while interestingly DAT was over 30 times more potent in the absence of S-9 than in its presence. In the latter case, a direct comparison can be made since the same treatment period of 4 hours was applied under both conditions. However, aromatic amines are generally assumed to be more genotoxic following metabolic activation. We have not yet found an explanation for this discrepancy. It seems possible that S-9 is relevant for the in vitro transformation of DAT to a mutagenic species (as demonstrated by the Ames results), which is not clastogenic and hence not detected by the chromosomal aberration assay. Furthermore, DAT may adsorb to microsomal proteins in the S-9 mix, resulting in a decreased concentration of free DAT. The described explanations are, however, not considered sufficient to support a 30-fold decrease in LOEC.
Taken together, all of the three aromatic amines investigated showed a clastogenic potential in cultured mammalian cells.
All N-acetylated metabolites tested completely lack a genotoxic potential in any of the investigated endpoints As opposed to their parent compounds, we could not detect a mutagenic potential of any of the five N-acetylated derivatives of DAT or PPD in the S. typhimurium reversion assay. Figures  7 and 5 illustrate the effect of N-acetylation of PPD and DAT on revertant colony counts in strain TA98 in the presence of metabolic activation. This strain showed the strongest response to the compounds investigated in this study.
In line with the Ames results, and again in sharp contrast to the parent substances, the mono-and diacetylated derivatives of DAT and Ac-AHT did not cause biologically relevant induction of micronuclei at concentrations of up to ~10 mM or up to the limit defined by their cytotoxicity. We did not perform a micronucleus test with 5-mono-Ac-DAT, the structural isomer of 2-mono-Ac-DAT, but found no genotoxic potential in any of the isomers with the Comet assay. Since DAT is positive at very low concentrations in the Comet assay and has been demonstrated to be clastogenic (supplementary Table SI4 , available at Mutagenesis Online), we expect the Comet assay to correctly detect the clastogenic potential of all its derivatives. Analogous to what we have found for the mono-and diacetylated metabolites of DAT and Ac-AHT, a lack of genotoxic potential in the in vitro micronucleus assay had been reported previously for the monoand diacetylated derivatives of PPD by Garrigue et al. (14) .
None of the N-acetylated derivatives, when assessed under the same conditions as their respective parent compounds, showed any genotoxic activity in the Comet assay.
NAT -proficient cell lines are less susceptible to the clastogenic effects of the test compounds than V79 cells
V79NAT1*4 cells have been derived from standard V79 cells through transfection, and express NAT 1*4 (NAT1*4), which is the prevalent NAT1 isoform in human skin (24, 46, 47) . Another cell model that expresses human NAT1 is HaCaT, a cell line based on human keratinocytes (2, 48) . Both cell lines have been shown to possess substantial capacity for the biotransformation of aromatic amine hair dye precursor molecules (2) . HaCaT cells are derived from human skin and per se differ from V79 rodent fibroblast cells. Differences in growth kinetics, protein content, p53 status and DNA repair capacity exist, and it might be argued that these differences may possibly contribute to their observed lower susceptibility towards aromatic amines. However, transfected V79NAT1*4 cells are practically identical to the 'standard/parent' V79 cells since they are derived from these cells and therefore the above-mentioned differences do not apply. Hence, the observed shift of the toxicity curve towards higher concentrations clearly points to a true detoxification effect through NAT activity.
In order to provide an overview of the Comet data and illustrate the differences between cell lines and test chemicals, an overview of the data is shown in Table III . A quantitative assessment of the reduction in genotoxic potential is not straightforward. One could, for example, compare LOEC, effect levels and slopes of dose-response curves. Using such methods for our results, however, may not be suitable due to the paucity of data at doses close to the inflection points of the dose-response curves. For that reason, we believe that it is difficult to 'rank' the detoxifying effects for the three molecules investigated and the different cell types used. Therefore, we do not elaborate further in this direction but simply point to the substantial difference between the curves in each case.
'Overloading' of the NAT-proficient cells leads to DNA damage in both metabolically competent cell systems
The observed shift of dose-response curves towards higher concentrations in the experiments with NAT-proficient cell lines confirms our hypothesis of N-acetylation being a detoxification pathway. Relevant increases in Comet TI% occur at substantially higher concentrations, demonstrating the capacity of these cells to N-acetylate and thereby detoxify the active metabolite. At the same time, the general sensitivity of these cell lines towards aromatic amine effects was proven. One notable exception is PPD when tested in V79NAT1*4, which did not cause clastogenicity after 3 hours of exposure but did so following 6 hours of exposure (data not shown).
It is reasonable to assume that the N-acetylation capacity of HaCaT and V79NAT1*4 cells will be exceeded at some pointthe biological system is 'overloaded'. This will happen through the limitations of enzyme capacity and kinetics, but cofactor depletion may also play an important role. This could be further investigated, e.g. by manipulation of the Acetyl-CoA status of the cells. Taken together, these experiments demonstrate that the NAT activity eliminates the genotoxicity of the tested hair dye precursors at low doses but can be overwhelmed by high concentrations of aromatic amines. This finding is indicative of a threshold for dermally applied aromatic amines (substrates of NAT) up to which the skin is able to completely detoxify the parent compound.
Even with a remaining free amine group, mono-N-acetyl derivatives of the diamines are devoid of a genotoxic potential Monoacetylated compounds with one amine function remaining in para position to the N-acetyl moiety were not genotoxic in our studies. While one may expect that the remaining free amine group could still be sufficient to cause a genotoxic effect, the observed absence of DNA reactivity is in line with the observation of Aeby et al. (43) . These authors had tested mono-and diacetylates of PPD for their ability to induce an allergic reaction in the mouse local lymph node assay, as well as whether these molecules can activate dendritic cells in vitro, and could not find any activity.
AHT shows genotoxic effects in the Comet assay only after prolonged treatment
The 3-hour standard treatment period chosen for our Comet experiments is a generally accepted compromise to detect both rapid-acting genotoxins (for which repair of DNA damage most likely is not completed after 3 hours even if the test substance itself may already be cleared from the biological system) and slow-acting genotoxins, which must be metabolised to show clastogenicity. We found a significant effect following 24 hours of AHT exposure (data not shown) but not after 3 hours of exposure, and decided to investigate an even longer treatment period (48 hours) to maximise effect and sensitivity/detection limit of the assay.
The reasons for the delayed response to AHT, which showed the strongest effect after 48 hours, are not clear. It seems likely, however, that some rudimentary oxidative metabolism is performed by V79 cells, which would lead to the generation of genotoxic metabolite(s) in minute amounts.
Conclusion
Summarizing the above data, we conclude that N-acetylation is a detoxification reaction for the three aromatic amine hair dye precursor molecules investigated. All observed N-acetylated metabolites completely lack genotoxic potential as shown in the S. typhimurium reversion assay, micronucleus test and Comet assay performed with V79 cells. Monoacetylation is sufficient to completely abolish the genotoxic potential of the bifunctional aromatic amines studied here.
Concluding from the three substances investigated in the described study, detoxification of aromatic amines by N-acetylation seems to be a generally applicable concept. However, it should not be confused with O-acetylation of N-hydroxylated compounds, leading to mutagenic esters. The resulting -O-COCH 3 O-acetyl species can be readily converted to the highly reactive nitrenium ion. In a recent study by Shamovsky et al. (6) , the authors conclude that a key factor in the mutagenic potential of aromatic amines is whether the molecule has high affinity to bind with CYP 1A2. However, our data seem to show that the affinity of the NH-group with NAT and other Phase II enzymes also plays a key role. It may, therefore, be possible to determine the genotoxic potential of aromatic amines by comparing the affinity of the molecule for NAT and CyP1A2, i.e, if a given compound is N-acetylated faster than being N-hydroxylated, it will likely not show a genotoxic potential.
However, since the substrate specificity and kinetics of the reactions described seem major factors influencing the genotoxicity of aromatic amines, another influential parameter for human risk assessment will be the exposure route. Due to the relatively high dermal NAT and low CYP1A2 activity (49), a 'first-pass effect' in skin should be taken into account for topically applied aromatic amines (2) . NAT should be able to detoxify these compounds at low concentrations and prevent them from being metabolised in the liver to a genotoxic species. This 'dermal first-pass' effect is not modelled by the currently used in vitro assays, which utilise induced rat liver S-9 mix, thereby favouring oxidative metabolism, which will lead to the generation of mutagenic hydroxylamines. Positive results generated under these conditions may, therefore, not be relevant for the >1642 (no effect) NT NT 5-Mono-Ac-DAT >1642 (1.2×) NT NT Di-Ac-DAT >2062 (1.2×) NT NT PPD 100 (7.1×) 1200 (2×) >1200 (1.6×) Mono-Ac-PPD >1500 (no effect) NT NT Di-Ac-PPD >1922 (no effect) NT NT AHT 10 (12.4×) 31.6 (2.6×) 100 (6.1×) Ac-AHT >1200 (1.3×) NT NT Test substances are listed in the left column, lowest observed effect level (LOEL) and maximum fold increase over concurrent solvent control are given. Please note that no LOEL can be assigned for overall negative studies and hence the '>' symbol is used. NT, not tested.
dermal route of exposure. This assumption is further supported by the degree of N-acetylation in skin under realistic exposure conditions. Several researchers have found nearly complete metabolism of parent compounds to N-acetylated or conjugated N-acetyl species following exposure to PPD, AHT and DAT applied to human subjects or reconstructed human skin models (8, 15, 50) . It is important to mention that for similar reasons (lack of adequate detoxification in the standard in vitro test systems), the unfavorable results for all three investigated hair dye precursors were not reproduced in in vivo genotoxicity assays (31, 37, 51) . Taken together, the lack of genotoxicity observed for N-acetylated metabolites of three aromatic amine hair dye precursors confirms previous findings that N-acetylation of aromatic amines represents a detoxification reaction and that the use of induced liver S-9 preparations may contribute to irrelevant positive results in standard genotoxicity tests for this chemical class. The use of reconstructed human skin models and modified cell lines that express key enzymes present in human skin therefore seems a better choice for determining the genotoxic properties of dermally applied aromatic amines.
Supplementary data
Supplementary Tables SI1-SI20 are available at Mutagenesis Online.
